Nature Communications (Aug 2021)
Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery
- Chengqian Feng,
- Jingrong Shi,
- Qinghong Fan,
- Yaping Wang,
- Huang Huang,
- Fengjuan Chen,
- Guofang Tang,
- Youxia Li,
- Pingchao Li,
- Jiaojiao Li,
- Jianping Cui,
- Liliangzi Guo,
- Sisi Chen,
- Mengling Jiang,
- Liqiang Feng,
- Ling Chen,
- Chunliang Lei,
- Changwen Ke,
- Xilong Deng,
- Fengyu Hu,
- Xiaoping Tang,
- Feng Li
Affiliations
- Chengqian Feng
- Guangzhou Eighth People’s Hospital, Guangzhou Medical University
- Jingrong Shi
- Guangzhou Eighth People’s Hospital, Guangzhou Medical University
- Qinghong Fan
- Guangzhou Eighth People’s Hospital, Guangzhou Medical University
- Yaping Wang
- Guangzhou Eighth People’s Hospital, Guangzhou Medical University
- Huang Huang
- Guangzhou Eighth People’s Hospital, Guangzhou Medical University
- Fengjuan Chen
- Guangzhou Eighth People’s Hospital, Guangzhou Medical University
- Guofang Tang
- Guangzhou Eighth People’s Hospital, Guangzhou Medical University
- Youxia Li
- Guangzhou Eighth People’s Hospital, Guangzhou Medical University
- Pingchao Li
- Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
- Jiaojiao Li
- Guangzhou Eighth People’s Hospital, Guangzhou Medical University
- Jianping Cui
- Guangzhou Eighth People’s Hospital, Guangzhou Medical University
- Liliangzi Guo
- Guangzhou Eighth People’s Hospital, Guangzhou Medical University
- Sisi Chen
- Guangzhou Eighth People’s Hospital, Guangzhou Medical University
- Mengling Jiang
- Guangzhou Eighth People’s Hospital, Guangzhou Medical University
- Liqiang Feng
- Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
- Ling Chen
- Guangzhou Eighth People’s Hospital, Guangzhou Medical University
- Chunliang Lei
- Guangzhou Eighth People’s Hospital, Guangzhou Medical University
- Changwen Ke
- Guangdong Provincial Center for Disease Control and Prevention
- Xilong Deng
- Guangzhou Eighth People’s Hospital, Guangzhou Medical University
- Fengyu Hu
- Guangzhou Eighth People’s Hospital, Guangzhou Medical University
- Xiaoping Tang
- Guangzhou Eighth People’s Hospital, Guangzhou Medical University
- Feng Li
- Guangzhou Eighth People’s Hospital, Guangzhou Medical University
- DOI
- https://doi.org/10.1038/s41467-021-25312-0
- Journal volume & issue
-
Vol. 12,
no. 1
pp. 1 – 7
Abstract
The quality of immune response to SARS-CoV-2 is thought to wane over time, but it is unclear how long it can persist. Here the authors show persistent immune responses in a large number of patients over the course of a 1-year follow-up from the time of recovery from COVID-19.
